Bay Area Reporter :: FDA approves long-acting injectable PrEP
The federal Food and Drug Administration has approved Apretude (extended-release cabotegravir), the first long-acting injectable option for HIV prevention.
Source: ebar.com
Page 20 - Mitchell Warren News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mitchell Warren. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mitchell Warren Today - Breaking & Trending Today
FDA Approves First Long-Acting Injectable to Prevent HIV Infection
Apretude is administered every 2 months versus a daily pill
Source: medpagetoday.com
An HIV-prevention drug is widely available. Yet at-risk women are getting left behind.
In the U.S., women account for a fifth of new infections. But a persistent lack of education means few even know about the highly effective medication known as PrEP.
Source: nationalgeographic.com
An HIV-Prevention Drug Is Widely Available. Yet At-Risk Women Are Getting Left Behind. - Economic Hardship Reporting Project
In the U.S., women account for a fifth of new infections. But a persistent lack of education means few even know about the highly effective medication known as PrEP.
Source: economichardship.org
Moderna and San Diego scientists race to make an HIV vaccine
Researchers plan to use a series of shots to teach people’s immune systems to produce powerful antibody responses against the virus.
Source: lajollalight.com